Objective: We examined a cohort of Australian sufferers with statin exposure who developed a necrotizing autoimmune myopathy (NAM) associated with a novel autoantibody against 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and describe the clinical and therapeutic difficulties of managing these individuals and an optimal therapeutic strategy. steroid therapy, with 5 relapsing upon efforts to wean steroids. Both… Continue reading Objective: We examined a cohort of Australian sufferers with statin exposure